CXCL8 and cancer: In fact, IL-8 is a proangiogenic factor produced by tumor-infiltrating macrophages and other tissues, whose levels rise with exposure to sunitinib in several cancers, including PNETs [13, 22], which would appear to be part of a mechanism of drug resistance [23].